In addition, the 2 prospective studies conducted by Gonzalez et al. reported significantly increased serum TNF-α levels and CSF TNF-α and IFN-γ levels in patients with PPS before IVIg treatment compared with those with other noninflammatory neurological diseases (ONDs) [5,13]. Here, TNF is linked to nervous system disorder.